Sign Out
No clinical benefit has been demonstrated in patients with prostate cancer treated with Finasteride. Prior to initiating therapy with Finasteride appropriate evaluation should be performed to identify other conditions such as prostate cancer.
No dosage adjustment is necessary in the elderly (70 and over), although the elimination rate of Finasteride is decreased in the elderly.
Is not indicated for use in pregnant and nursing women, and children.
Should be carefully monitored for obstructive uropathy.
Caution should be used in the administration of Finasteride in those patients with liver function abnormalities.
After 6 months of treatment should be necessary to evaluated.
Lanjutkan dengan Google